<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99126">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01892358</url>
  </required_header>
  <id_info>
    <org_study_id>DA034957</org_study_id>
    <secondary_id>1210-003</secondary_id>
    <nct_id>NCT01892358</nct_id>
  </id_info>
  <brief_title>Preventing Bacterial and Viral Infections Among Injection Drug Users</brief_title>
  <official_title>Preventing Bacterial and Viral Infections Among Injection Drug Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Butler Hospital</source>
  <oversight_info>
    <authority>United States: National Institutes of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We propose a randomized controlled trial (RCT) of the Skin intervention, compared to an
      assessment-only condition (both groups receive rapid HIV testing, a review of testing
      results, and brief HIV prevention counseling) among 350 injection drug users recruited
      during an acute medical hospitalization at Boston Medical Center. In the general hospital
      setting, injection drug users who otherwise might not seek care are accessible and
      teachable, and the presence of a drug-related illness can set the stage for patients to be
      more receptive to interventions2. We hypothesize that the Skin intervention will produce
      better outcomes at 1-, 3-, 6-, 9-, and 12-month(s) post-intervention.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>bacterial infections</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>high-risk behavior</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>health service use</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Bacterial Infection</condition>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>SKIN Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Assessment-Only</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SKIN Intervention</intervention_name>
    <arm_group_label>SKIN Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  report injection of heroin, cocaine, or methamphetamine (meth) on at least three
             different days in the week prior to admission

          -  have injected heroin, cocaine, or meth for at least three months

          -  positive urine screen for heroin, cocaine, or meth

        Exclusion Criteria:

          -  currently psychotic (e.g., responding to internal stimuli through observed
             hallucinations or delusions), homicidal or suicidal

          -  cannot provide informed consent

          -  not able to complete interviews in English (expected to exclude &lt;5% of IDUs)

          -  in police custody, expecting incarceration

          -  unable to provide names and contact information for at least two verifiable locator
             persons who will know where to find them for retention/follow-up purposes

          -  plan to move out of the Boston area in the next 12 months.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Stein, MD</last_name>
    <phone>401-455-6646</phone>
    <email>mstein@butler.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Stein, MD</last_name>
      <phone>401-455-6646</phone>
      <email>mstein@butler.org</email>
    </contact>
    <investigator>
      <last_name>Michael Stein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 3, 2013</lastchanged_date>
  <firstreceived_date>July 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Butler Hospital</investigator_affiliation>
    <investigator_full_name>Michael Stein, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>injection drug use</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
